|
[1]
|
Hostettler, I.C., Seiffge, D.J. and Werring, D.J. (2019) Intracerebral Hemorrhage: An Update on Diagnosis and Treat-ment. Expert Review of Neurotherapeutics, 19, 679-694. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Pires, P.W., Dams Ramos, C.M., Matin, N. and Dorrance, A.M. (2013) The Effects of Hypertension on the Cerebral Circulation. The American Journal of Physiology-Heart and Circulatory Physiology, 304, H1598-H1614. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Charidimou, A., Schmitt, A., Wilson, D., Fox, Z., et al. (2017) The Cerebral Haemorrhage Anatomical Rating Instrument (CHARTS): Development and Assessment of Reliability. Journal of the Neurological Sciences, 372, 178-183. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Rodrigues, M.A., Samarasekera, N., Lerpiniere, C., et al. (2018) The Edinburgh CT and Genetic Diagnostic Criteria for Lobar Intracerebral Haemorrhage Associated with Cerebral Amyloid Angiopathy: Model Development and Diagnostic Test Accuracy Study. The Lancet Neurology, 17, 232‐240. [Google Scholar] [CrossRef]
|
|
[5]
|
Delcourt, C., Sato, S., Zhang, S., et al. (2017) Intracerebral Hemorrhage Location and Outcome among INTERACT2 Participants. Neurology, 88, 1408-1414. [Google Scholar] [CrossRef]
|
|
[6]
|
Jing, J., Pan, Y., Zhao, X., Zheng, H., Jia, Q., Mi, D., et al. (2017) Insulin Resistance and Prognosis of Nondiabetic Patients with Ischemic Stroke: The ACROSS-China Study (Abnormal Glucose Regulation in Patients with Acute Stroke across China). Stroke, 48, 887-893. [Google Scholar] [CrossRef]
|
|
[7]
|
Bas, D.F., Ozdemir, A.O., Colak, E. and Kebapci, N. (2016) Higher Insulin Resistance Level Is Associated with Worse Clinical Response in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis. Translational Stroke Research, 7, 167-171. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kernan, W.N., Inzucchi, S.E., Viscoli, C.M., Brass, L.M., Bravata, D.M. and Horwitz, R.I. (2002) Insulin Resistance and Risk for Stroke. Neurology, 59, 809-815. [Google Scholar] [CrossRef]
|
|
[9]
|
Akhtar, A. and Sah, S.P. (2020) Insulin Signaling Pathway and Relat-ed Molecules: Role in Neurodegeneration and Alzheimer’s Disease. Neurochemistry International, 135, Article ID: 104707. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Howard, G., Wagenknecht, L.E., Kernan, W.N., Cushman, M., Thacker, E.L., Judd, S.E., et al. (2014) Racial Differences in the Association of Insulin Resistance with Stroke Risk: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke, 45, 2257-2262. [Google Scholar] [CrossRef]
|
|
[11]
|
Lee, J.E., Shin, D.W., Yun, J.M., Kim, S.H., Nam, Y.S., Cho, B., et al. (2016) Insulin Resistance Is a Risk Factor for Silent Lacunar Infarction. Stroke, 47, 2938-2944. [Google Scholar] [CrossRef]
|
|
[12]
|
Hemphill, J.C., Greenberg, S.M. anderson, C.S., Becker, K., Bendok, B.R., Cushman, M., et al. (2015) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 46, 2032-2060. [Google Scholar] [CrossRef]
|
|
[13]
|
Kemal, A., Teshome, M.S., Ahmed, M., Molla, M., Malik, T., Mohammed, J., et al. (2020) Dyslipidemia and Associated Factors among Adult Patients on Antiretroviral Therapy in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia. HIV AIDS (Auckl), 12, 221-231. [Google Scholar] [CrossRef]
|
|
[14]
|
Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthise-karan, D., Sethi, G., et al. (2013) The Vascular Endothelium and Human Diseases. International Journal of Biological Sciences, 9, 1057-1069. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Gerhardt, T. and Ley, K. (2015) Monocyte Trafficking across the Vessel Wall. Cardiovascular Research, 107, 321-330. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Gorski, D.H. and Walsh, K. (1995) Mitogen-Responsive Nuclear Factors That Mediate Growth Control Signals in Vascular Myocytes. Cardiovascular Research, 30, 585-592. [Google Scholar] [CrossRef]
|
|
[17]
|
Norata, G.D. and Catapano, A.L. (2005) Molecular Mecha-nisms Responsible for the Antiinflammatory and Protective Effect of HDL on the Endothelium. Vascular Health and Risk Management, 1, 119-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Chang, J.J., Katsanos, A.H., Khorchid, Y., Dillard, K., Kerro, A., Burgess, L.G., et al. (2018) Higher Low-Density Lipoprotein Cholesterol Levels Are Associated with Decreased Mortal-ity in Patients with Intracerebral Hemorrhage. Atherosclerosis, 269, 14-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Liu, J., Sempos, C.T., Donahue, R.P., Dorn, J., Trevisan, M. and Grundy, S.M. (2006) Non-High-Density Lipoprotein and Very-Low-Density Lipoprotein Cholesterol and Their Risk Predictive Values in Coronary Heart Disease. American Journal of Cardiology, 98, 1363-1368. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ingelsson, E., Schaefer, E.J., Contois, J.H., McNamara, J.R., Sullivan, L., Keyes, M.J., et al. (2007) Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women. JAMA, 298, 776-785. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Wang, Y., Zhang, J., Qian, Y.S., Tang, X.F., Ling, H.W., Chen, K.M., Li, Y., Gao, P.J. and Zhu, D.L. (2018) Association of Homocysteine with Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients. Scientific Reports, 8, Article No. 595. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wu, X., Zhou, Q., Chen, Q., Li, Q., Guo, C., Tian, G., et al. (2020) Association of Homocysteine Level with Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Cohort Studies. Nutrition, Metabolism & Cardiovascular Diseases, 30, 1861-1869. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Chen, S., Dong, Z.P., Cheng, M., Zhao, Y.Q., Wang, M.Y., Sai, N., Wang, X., Liu, H., Huang, G.W. and Zhang, X.M. (2017) Homocysteine Exaggerates Microglia Activation and Neuroinflammation through Microglia Localized STAT3 Overactivation Following Ischemic Stroke. Journal of Neuroin-flammation, 14, 187. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Ye, Z.S., Zhang, Z.Z., Zhang, H., Hao, Y.G., Zhang, J., Liu, W.H., Xu, G.L. and Liu, X.F. (2017) Prognostic Value of C-Reactive Protein and Homocysteine in Large-Artery Ather-osclerotic Stroke: A Prospective Observational Study. Journal of Stroke and Cerebrovascular Diseases, 26, 618-626. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Yuan, K., Zhang, X., Chen, J., et al. (2020) Uric Acid Level and Risk of Symptomatic Intracranial Haemorrhage in Ischaemic Stroke Treated with Endovascular Treatment. European Journal of Neurology, 27, 1048-1055. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Wang, Q., Wen, X. and Kong, J. (2020) Recent Progress on Uric Acid De-tection: A Review. Critical Reviews in Analytical Chemistry, 50, 359-375. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lee, S.W., Kim, H.C., Nam, C., Lee, H.Y., Ahn, S.V., Oh, Y.A., et al. (2019) Age-Differential Association between Serum Uric Acid and Incident Hypertension. Hypertension Re-search, 42, 428-437. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zapolski, T., Wacinski, P., Kondracki, B., Rychta, E., Buraczyn-ska, M.J. and Wysokinski, A. (2011) Uric Acid as a Link between Renal Dysfunction and both Pro-Inflammatory and Prothrombotic State in Patients with Metabolic Syndrome and Coronary Artery Disease. Kardiologia Polska, 69, 319-326.
|
|
[29]
|
Godoy, D.A. and Boccio, A. (2005) Early Neurologic Deterioration in Intracerebral Hemorrhage: Predic-tors and Associated Factors. Neurology, 64, 931-932. [Google Scholar] [CrossRef]
|
|
[30]
|
Kimura, Y., Yanagida, T., Onda, A., et al. (2020) Soluble Uric Acid Promotes Atherosclerosis via AMPK (Amp- Activated Protein Kinase)-Mediated Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 40, 570-582. [Google Scholar] [CrossRef]
|
|
[31]
|
Lord, A.S., Gilmore, E., Choi, H.A., et al. (2015) Time Course and Predictors of Neurological Deterioration after Intracerebral Hemorrhage. Stroke, 46, 647-652. [Google Scholar] [CrossRef]
|
|
[32]
|
Lerdal, A., Bakken, L.N., Rasmussen, E.F., Beiermann, C., Ryen, S., Pynten, S., Drefvelin, S.S., Dahl, A.M., Rognstad, G. and Finset, A. (2011) Physical Impairment, Depres-sive Symptoms and Pre-Stroke Fatigue Are Related to Fatigue in the Acute Phase after Stroke. Disability & Rehabilita-tion, 33, 334-342. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Wang, Y., Li, W., Yang, J., Zhang, M., Tian, C., Ma, M. and Zhang, Q. (2019) Association between Cystatin C and the Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis. Journal of Molecular Neuroscience, 69, 444-449. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Zeng, Q., Huang, Z., Wei, L., Fang, J. and Lin, K. (2019) Corre-lations of Serum Cystatin C Level and Gene Polymorphism with Vascular Cognitive Impairment after Acute Cerebral In-farction (Article). Neurological Sciences, 40, 1049- 1054. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Zhang, Y. and Sun, L. (2017) Cystatin C in Cerebrovascular Disorders. Current Neurovascular Research, 14, 406-414. [Google Scholar] [CrossRef] [PubMed]
|